Genesys board approves rights issue up to Rs 13,930 Lakhs
Genesys International Corporation Ltd's board approved a rights issue of equity shares to raise up to Rs 13,930 Lakhs, subject to regulatory approvals. The issue involves shares with a face value of Rs. 5/- each, with specific terms like the record date yet to be decided.

*this image is generated using AI for illustrative purposes only.
Genesys International Corporation Ltd has approved a rights issue of equity shares to raise funds up to Rs 13,930 Lakhs. The Board of Directors granted this approval at its meeting held on June 26, 2026, enabling the company to bolster its capital base through the issuance of shares to eligible shareholders. The specific terms of the issue, including the rights entitlement ratio and record date, are yet to be determined.
The equity shares will have a face value of Rs. 5/- each. The company stated that the issue is subject to regulatory and statutory approvals, including those under the Companies Act, 2013, and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018. A Rights Issue Committee has been constituted to oversee the offer, allotment, and related matters.
Key Meeting Details
| Detail | Information |
|---|---|
| Meeting Date | June 26, 2026 |
| Agenda | Rights issue approval |
| Total Amount | Up to Rs 13,930 Lakhs |
| Face Value | Rs. 5/- each |
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has informed BSE Limited and National Stock Exchange of India Ltd regarding the outcome. The official notice is available on the company's website at www.igenesys.com .
Historical Stock Returns for Genesys International Corp
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.75% | -2.46% | +4.27% | -7.75% | -49.96% | +92.03% |
What specific strategic initiatives or acquisitions does Genesys International plan to fund with the Rs 13,930 Lakhs raised?
How will the rights issue impact the company's earnings per share and existing shareholder equity dilution?
What is the expected timeline for receiving regulatory approvals and announcing the rights entitlement ratio?































